Pacific Biosciences
PACB
$8.74
Share price
1.27%
Change (1 day)
-10.08%
Change (1 year)
Categories
Operating Margin for Pacific Biosciences (PACB)
Operating Margin as of November 2023 (TTM): -218.42%
According to Pacific Biosciences 's latest financial reports and stock price the company's current Operating Margin is -218.42%. At the end of 2022 the company had an Operating Margin of -233.48%.
Operating Margin history for Pacific Biosciences from 2010 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -233.48% | 16.15% |
| 2021 | -201.01% | -634.48% |
| 2020 | 37.61% | -141.93% |
| 2019 | -89.69% | -29.58% |
| 2018 | -127.36% | 33.35% |
| 2017 | -95.51% | 21.78% |
| 2016 | -78.42% | 152.91% |
| 2015 | -31.01% | -70.33% |
| 2014 | -104.52% | -61.66% |
| 2013 | -272.58% | -24.93% |
| 2012 | -363.08% | 12.02% |
| 2011 | -324.12% | -96.13% |
| 2010 | -8,377.18% | -87.16% |
| 2009 | -65,237.04% | 1211.76% |
| 2008 | -4,973.25% | 359.88% |
| 2007 | -1,081.41% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 14.17% | -106.49% | 🇺🇸 USA |
 General Electric GE | -1.37% | -99.37% | 🇺🇸 USA |
 Illumina ILMN | -94.58% | -56.70% | 🇺🇸 USA |
 PerkinElmer
PKI | 14.13% | -106.47% | 🇺🇸 USA |
 Luminex LMNX | N/A | N/A | 🇺🇸 USA |
 NanoString Technologies NSTG | -116.24% | -46.78% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.